Cite
Acrolein adducts and responding autoantibodies correlate with metabolic disturbance in Alzheimer's disease.
MLA
Sanotra, Monika Renuka, et al. “Acrolein Adducts and Responding Autoantibodies Correlate with Metabolic Disturbance in Alzheimer’s Disease.” Alzheimer’s Research & Therapy, vol. 15, no. 1, June 2023, pp. 1–17. EBSCOhost, https://doi.org/10.1186/s13195-023-01261-2.
APA
Sanotra, M. R., Kao, S.-H., Lee, C.-K., Hsu, C.-H., Huang, W.-C., Chang, T.-C., Tu, F.-Y., Hsu, I.-U., & Lin, Y.-F. (2023). Acrolein adducts and responding autoantibodies correlate with metabolic disturbance in Alzheimer’s disease. Alzheimer’s Research & Therapy, 15(1), 1–17. https://doi.org/10.1186/s13195-023-01261-2
Chicago
Sanotra, Monika Renuka, Shu-Huei Kao, Ching-Kuo Lee, Chun-Hsien Hsu, Wen-Chung Huang, Tsuei-Chuan Chang, Fang-Yu Tu, I-Uen Hsu, and Yung-Feng Lin. 2023. “Acrolein Adducts and Responding Autoantibodies Correlate with Metabolic Disturbance in Alzheimer’s Disease.” Alzheimer’s Research & Therapy 15 (1): 1–17. doi:10.1186/s13195-023-01261-2.